{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-27",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "third_party_flag": "N",
      "city": "Toronto",
      "advisory_committee_description": "Pathology",
      "address_1": "Suite 1802, 393 University Ave.",
      "address_2": "",
      "statement_or_summary": "Summary",
      "product_code": "PZM",
      "openfda": {
        "registration_number": [
          "",
          "3013200421",
          "3003335080",
          "3043050156",
          "3011805506",
          "3043140667"
        ],
        "fei_number": [
          "",
          "3013200421",
          "3003335080",
          "3043050156",
          "3011805506",
          "3043140667"
        ],
        "device_name": "Next Generation Sequencing Based Tumor Profiling Test",
        "medical_specialty_description": "Pathology",
        "regulation_number": "866.6080",
        "device_class": "2"
      },
      "zip_code": "M5G 1E6",
      "applicant": "Geneseeq Technology, Inc.",
      "decision_date": "2025-08-29",
      "decision_code": "SESE",
      "country_code": "CA",
      "device_name": "GENESEEQPRIME NGS Tumor Profiling Assay (FFPE) (GS6005)",
      "advisory_committee": "PA",
      "contact": "Xue  Wu",
      "expedited_review_flag": "",
      "k_number": "K250003",
      "state": "",
      "date_received": "2025-01-02",
      "review_advisory_committee": "PA",
      "postal_code": "M5G 1E6",
      "decision_description": "Substantially Equivalent",
      "clearance_type": "Traditional"
    }
  ]
}